Axon Enterprise (NASDAQ:AXON) Given New $674.00 Price Target at Piper Sandler

Axon Enterprise (NASDAQ:AXON) had its target price decreased by Piper Sandler from $690.00 to $674.00 in a report issued on Thursday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the biotechnology company’s stock.

Other analysts also recently issued reports about the stock. Needham & Company LLC cut their price target on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a research report on Friday, February 20th. Citizens Jmp reissued a “market outperform” rating and set a $825.00 price target on shares of Axon Enterprise in a research report on Monday, April 13th. Barclays decreased their price target on shares of Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Finally, Robert W. Baird set a $800.00 target price on Axon Enterprise in a research note on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $712.75.

Axon Enterprise Price Performance

Shares of AXON stock traded down $32.64 during trading hours on Thursday, reaching $394.25. 1,045,698 shares of the company were exchanged, compared to its average volume of 1,060,959. The stock’s fifty day moving average is $451.93 and its two-hundred day moving average is $527.52. Axon Enterprise has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The company has a market cap of $31.77 billion, a price-to-earnings ratio of 158.16, a P/E/G ratio of 8.24 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.95% and a net margin of 6.90%.The company had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.91 million. During the same quarter in the previous year, the company posted $1.47 earnings per share. The firm’s quarterly revenue was up 33.7% on a year-over-year basis. Sell-side analysts forecast that Axon Enterprise will post 1.41 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, Director Erika Nardini sold 198 shares of the company’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total transaction of $100,302.84. Following the sale, the director directly owned 1,946 shares of the company’s stock, valued at approximately $985,804.68. This represents a 9.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the completion of the transaction, the insider directly owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This trade represents a 3.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,855 shares of company stock valued at $7,109,828 in the last quarter. 4.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise during the fourth quarter worth $28,000. Stone House Investment Management LLC acquired a new stake in Axon Enterprise during the third quarter worth approximately $29,000. New Millennium Group LLC bought a new stake in shares of Axon Enterprise during the third quarter worth approximately $29,000. Sound Income Strategies LLC boosted its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after acquiring an additional 44 shares during the period. Finally, Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $30,000. 79.08% of the stock is owned by institutional investors and hedge funds.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q1 revenue and guidance lift: Axon reported Q1 revenue of ~$807M (up ~34% YoY) and raised FY revenue growth to 30%–32%, reiterating strong cash‑flow targets—this underpins the case for durable growth. Axon reports Q1 2026 revenue of $807 million, up 34% year over year
• Positive Sentiment: AI & counter‑drone acceleration: Management highlighted AI product revenue up ~700% and counter‑drone bookings/revenue growing several hundred percent, helping drive the guidance raise and stronger bookings momentum. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Analyst support remains: Several firms maintained or raised bullish ratings (e.g., JPMorgan raised its price target), reflecting continued confidence in Axon’s growth runway. These notes can provide buying interest. Benzinga coverage of analyst actions
• Neutral Sentiment: Municipal order in Baltimore: The city approved a $153M police-equipment contract (body cameras, Tasers), which is incremental revenue and a commercial win but also drew competitive/price scrutiny that could attract political headlines. FOX45: Baltimore approves $153M contract for police equipment
• Neutral Sentiment: Mixed analyst notes and coverage: Media pieces emphasize bullish ARR/AI trends but also debate valuation — this creates two‑sided flows as some investors buy the growth story while others sit on the sidelines. Analysts Conflicted on These Industrial Goods Names
• Negative Sentiment: Margin / EPS pressure: While revenue beat, some coverage flagged an EPS miss vs certain estimates and tariff‑driven margin pressure — a reminder that profitability and cost headwinds matter to investors. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: Short‑term selling and valuation concerns: Despite the beat, shares have pulled back as some investors take profits after recent gains and others focus on a stretched P/E and several trimmed price targets — creating downward pressure. Assessing Axon Enterprise (AXON) Valuation After A Sharp Year To Date Share Price Decline

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.